Search Results - "OLSSON, A. G"

Long‐term Cardiac Outcomes in Renal Transplant Recipients Receiving Fluvastatin: The ALERT Extension Study by Holdaas, H., Fellström, B., Cole, E., Nyberg, G., Olsson, A.G., Pedersen, T.R., Madsen, S., Grönhagen‐Riska, C., Neumayer, H.‐H., Maes, B., Ambühl, P., Hartmann, A., Staffler, B., Jardine, A.G.

“…Renal transplant recipients (RTR) have an increased risk of premature cardiovascular disease. The ALERT study is the first trial to evaluate the effect of…”
Get full text

Can LDL cholesterol be too low? Possible risks of extremely low levels by Olsson, A. G., Angelin, B., Assmann, G., Binder, C. J., Björkhem, I., Cedazo‐Minguez, A., Cohen, J., Eckardstein, A., Farinaro, E., Müller‐Wieland, D., Parhofer, K. G., Parini, P., Rosenson, R. S., Starup‐Linde, J., Tikkanen, M. J., Yvan‐Charvet, L.

“…Following the continuous accumulation of evidence supporting the beneficial role of reducing low‐density lipoprotein cholesterol (LDL‐C) levels in the…”
Get full text

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) by PYORALA, K, OLSSON, A. G, PEDERSEN, T. R, THORGEIRSSON, G, KJEKSHUS, J, FAERGEMAN, O

“…Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin…”
Get full text

Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia by Maccubbin, D, Bays, H E, Olsson, A G, Elinoff, V, Elis, A, Mitchel, Y, Sirah, W, Betteridge, A, Reyes, R, Yu, Q, Kuznetsova, O, Sisk, C McCrary, Pasternak, R C, Paolini, J F

“…Improving lipids beyond low-density lipoprotein cholesterol (LDL-C) lowering with statin monotherapy may further reduce cardiovascular risk. Niacin has…”
Get more information

Impaired cortisol response to acute stressors in patients with coronary disease. Implications for inflammatory activity by Nijm, J., Kristenson, M., Olsson, A. G., Jonasson, L.

“… Objectives.  Inflammation is assumed to play a major role in the progress of atherosclerotic disease. We hypothesized that an altered hypothalamic‐pituitary…”
Get full text

Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment by Lind, S., Olsson, A. G., Eriksson, M., Rudling, M., Eggertsen, G., Angelin, B.

“… Background.  Severe hereditary hypercholesterolaemia is most frequently due to familial hypercholesterolaemia (FH), caused by mutations in the LDL receptor…”
Get full text

Well-being in patients with amyotrophic lateral sclerosis and their next of kin over time by Olsson, A. G., Markhede, I., Strang, S., Persson, L. I.

“…Olsson AG, Markhede I, Strang S, Persson LI. Well‐being in patients with amyotrophic lateral sclerosis and their next of kin over time. 
Acta Neurol Scand:…”
Get full text

Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris : Findings from the Scandinavian Simvastatin Survival Study (4S) by MIETTINEN, T. A, PYÖRÄLÄ, K, OLSSON, A. G, MUSLINER, T. A, COOK, T. J, FAERGEMAN, O, BERG, K, PEDERSEN, T, KJEKSHUS, J

“…The Scandinavian Simvastatin Survival Study (4S) demonstrated pronounced reductions in mortality and major coronary events in a cohort of patients with…”
Get full text

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) by PEDERSEN, T. R, OLSSON, A. G, MIETTINEN, T, CHRISTOPHERSEN, B, TOBERT, J. A, MUSLINER, T. A, COOK, T. J, FAERGEMAN, O, KJEKSHUS, J, WEDEL, H, BERG, K, WILHELMSEN, L, HAGHFELT, T, THORGEIRSSON, G, PYÖRÄLÄ, K

“…The Scandinavian Simvastatin Survival Study (4S) randomized 4444 patients with coronary heart disease (CHD) and serum cholesterol 5.5 to 8.0 mmol/L (213 to 310…”
Get full text

Effect of Simvastatin on Ischemic Signs and Symptoms in the Scandinavian Simvastatin Survival Study (4S) by Pedersen, Terje R, Kjekshus, John, Pyörälä, Kalevi, Olsson, Anders G, Cook, Thomas J, Musliner, Thomas A, Tobert, Jonathan A, Haghfelt, Torben

“…In patients participating in the Scandinavian Simvastatin Survival Study, cholesterol lowering with simvastatin reduced the incidence of carotid bruits and…”
Get full text

Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering by Pedersen, Terje R., Wilhelmsen, Lars, Færgeman, Ole, Strandberg, Timo E., Thorgeirsson, Gudmundur, Troedsson, Linda, Kristianson, Johan, Berg, Kåre, Cook, Thomas J., Haghfelt, Torben, Kjekshus, John, Miettinen, Tatu, Olsson, Anders G., Pyörälä, Kalevi, Wedel, Hans

“…The Scandinavian Simvastatin Survival Study (4S) and other randomized clinical trials have demonstrated that cholesterol-lowering treatment with statins…”
Get full text

Increased Plasma 7 beta-Hydroxycholesterol Concentrations in a Population With a High Risk for Cardiovascular Disease by Zieden, Bo, Kaminskas, Arvydas, Kristenson, Margareta, Kucinskiene, Zita, Vessby, Bengt, Olsson, Anders G, Diczfalusy, Ulf

“…The mortality in coronary heart disease among 50- to 54-year-old men is 4 times higher in Lithuania than in Sweden. It was recently suggested that traditional…”
Get full text

Differential recruitment of the coactivator proteins CREB-binding protein and steroid receptor coactivator-1 to peroxisome proliferator-activated receptor gamma/9-cis-retinoic acid receptor heterodimers by ligands present in oxidized low-density lipoprotein by Wigren, J, Surapureddi, S, Olsson, AG, Glass, CK, Hammarstrom, S, Soderstrom, M

“…Peroxisome proliferator-activated receptor gamma (PPARgamma) colocalizes with oxidized low-density lipoprotein (LDL) in foam cells in atherosclerotic lesions…”
Get full text

Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S) by Jönsson, B, Johannesson, M, Kjekshus, J, Olsson, A G, Pedersen, T R, Wedel, H

“…An analysis of the cost-effectiveness of simvastatin was conducted, based on the Scandinavian Simvastatin Survival Study (4S). The total cost of…”
Get full text

Quality of life in patients with familial hypercholesterolaemia by HOLLMAN, G., GULLBERG, M., EK, A.‐C., ERIKSSON, M., OLSSON, A. G.

“… Hollman G, Gullberg M, Ek A.‐C, Eriksson M, Olsson AG (University of Linköping, Linköping; Huddinge University Hospital, Stockholm, Sweden). Quality of life…”
Get full text

Uptake of Oxidized LDL by Macrophages Results in Partial Lysosomal Enzyme Inactivation and Relocation by Li, Wei, Yuan, Xi Ming, Olsson, Anders G, Brunk, Ulf T

“…The cytotoxicity of oxidized LDL (oxLDL) to several types of artery wall cells might contribute to atherosclerosis by causing cell death, presumably by both…”
Get full text

Risk factors for reaching renal endpoints in the Assessment of Lescol in Renal Transplantation (ALERT) trial by FELLSTRÖM, Bengt, HOLDAAS, Hallvard, OLSSON, Anders G, STAFFLER, Beatrix, PEDERSEN, Terje R, JARDINE, Alan G, NYBERG, Gudrun, GRDNHAGEN-RISKA, Carola, MADSEN, Søren, NEUMAYER, Hans-Hellmut, COLE, Edward, MAES, Bart, AMBÜHL, Patrice

“…The aim of the study was to identity risk factors for long-term renal transplant function and development of chronic allograft nephropathy (CAN) in renal…”
Get full text

Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication by Mölgaard, J, Malinow, M R, Lassvik, C, Holm, A C, Upson, B, Olsson, A G

“…The aim of this study was to test the question of hyperhomocyst(e)inaemia as a risk factor for intermittent claudication (IC) independent of other important…”
Get more information

A dose titration model for recombinant GH substitution aiming at normal plasma concentrations of IGF-I in hypopituitary adults by EKMAN, B, LINDSTRÖM, T, NYSTRÖM, F, OLSSON, A. G, TOSS, G, ARNQVIST, H. J

“…To evaluate a dose titration model for recombinant human GH substitution in adult patients with GH deficiency, aiming at normal plasma levels of IGF-I…”
Get full text

Addressing the challenge by OLSSON, A. G

“…Patients with hypercholesterolaemia are at an increased risk of coronary heart disease. Lowering elevated cholesterol levels has been shown to reduce…”
Get full text